The U.S. Supreme Court on Wednesday denied an emergency request from the Trump administration to immediately enforce a policy restricting gender-affirming medical care for transgender inmates in federal custody.
The policy, which was issued by the Federal Bureau of Prisons in February to implement a January 2025 executive order signed by President Donald Trump, sought to limit medical interventions and social accommodations—such as hormone therapy and gender-transition surgeries. The executive order mandated that federal agencies reject gender identity outside of an “immutable biological classification.” The Bureau of Prisons had provided hormone therapy to inmates since 1992.
Earlier this year, District Judge Royce Lamberth blocked the proposal, concluding that the Bureau of Prisons failed to provide evidence that the previous, more accommodating healthcare plan was “ineffective or harmful.” The administration’s emergency appeal to the Supreme Court argued that the lower court’s injunction interfered with the “expert judgment” of prison administrators.
However, the Supreme Court’s justices left the lower court’s ruling intact, affecting approximately 1,000 transgender inmates currently in federal prisons. Justices Clarence Thomas and Samuel Alito dissented from the decision, stating they would have granted the administration’s request.
The ruling marks a rare victory for transgender advocates before the 6-3 conservative majority court, which has previously allowed the administration to implement bans on transgender military service and has upheld state-level restrictions on transgender athletes and youth treatments. The policy continues to face ongoing legal challenges from organizations like the American Civil Liberties Union and the Transgender Law Center.


